Gene Therapy Market size was USD 7.7 Billion in 2022 and is projected to reach USD 35.1 Billion by 2032

The gene therapy market size was USD 7.7 Billion in 2022 and is projected to reach USD 35.1 Billion by 2032 with a CAGR of 16.4%.
Read More: https://www.globenewswire.com/news-release/2023/09/27/2750007/0/en/Gene-Therapy-Market-Size-to-Reach-USD-35-1-Billion-By-2032-CAGR-16-4-Report-By-DataHorizzon-Research.html

Gene therapy is a rapidly evolving field in biotechnology that holds immense promise for treating a wide array of genetic disorders by replacing, inactivating, or introducing genes into a patient’s cells. This approach aims to address the root cause of diseases rather than just managing their symptoms, offering potentially curative solutions.

In recent years, the gene therapy market has witnessed significant growth driven by advancements in molecular biology, gene editing technologies like CRISPR-Cas9, and improved delivery mechanisms such as viral vectors. Addition